<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913696/" ref="ordinalpos=2754&amp;ncbi_uid=5791170&amp;link_uid=PMC3913696" image-link="/pmc/articles/PMC3913696/figure/pone-0087810-g008/" class="imagepopup">Figure 8. CK prevents inflammatory responses via inhibiting NF-κB <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> activation..  From: Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium-Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-?B Activation. </a></div><br /><div class="p4l_captionBody">CK exerts therapy effects on the progression of DSS-induced colitis in mice, and the potential mechanisms may contribute to regulating the innate immune cells such as macrophages activities through modulating NF-κB signaling pathways activation.</div></div>